Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.

MLA

Xu, Yuexuan, et al. “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.” Journal of Alzheimer’s Disease, vol. 94, no. 4, Aug. 2023, pp. 1587–605. EBSCOhost, https://doi.org/10.3233/JAD-230097.

APA

Xu, Y., Vasiljevic, E., Deming, Y. K., Jonaitis, E. M., Koscik, R. L., Van Hulle, C. A., Lu, Q., Carboni, M., Kollmorgen, G., Wild, N., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., & Engelman, C. D. (2023). Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. Journal of Alzheimer’s Disease, 94(4), 1587–1605. https://doi.org/10.3233/JAD-230097

Chicago

Xu, Yuexuan, Eva Vasiljevic, Yuetiva K. Deming, Erin M. Jonaitis, Rebecca L. Koscik, Carol A. Van Hulle, Qiongshi Lu, et al. 2023. “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.” Journal of Alzheimer’s Disease 94 (4): 1587–1605. doi:10.3233/JAD-230097.